PCIF1‐mediated m6Am modification has been shown to promote tumourigenesis in several cancers, including colorectal cancer, glioblastoma and gastric cancer, by enhancing the stability and translation of oncogenic mRNAs.12, 13, 16, 19. This evidence concerns the gene PCIF1 and glioblastoma.